Flavonoid Diosmetin Prevents Periodontitis via Synergistic Anti‐Inflammatory and Osteogenic Effects: Dual In Vitro/In Vivo Validation
Oral Diseases · 2026-09 · 32 (9) · 2898-2911
DOI: 10.1111/odi.70370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 05.06.2026. Verfasst von Yujun Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Stomatological Hospital of Guizhou Medical University, Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Osteogenesis, Periodontitis, Anti-Inflammatory Agents, Flavonoids. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Natural Science Foundation, Science-Technology Foundation of Health Commission of Guizhou Province.
Abstract (Originalsprache)
Objective
Periodontitis is a chronic inflammatory disorder affecting periodontal tissues; diosmetin, exhibiting anti‐inflammatory and anti‐osteoporotic properties, emerges as a promising novel agent for periodontitis prevention.
Methods
In this study, we utilized in vitro primary hPDLCs cultures and in vivo ligature‐induced periodontitis models in rats to demonstrate the dual anti‐inflammatory and osteogenic effects of diosmetin, alongside its protective role against alveolar bone resorption in periodontal disease.
Results
CCK‐8 assays demonstrated that diosmetin exhibited no cytotoxicity in hPDLCs at concentrations up to 100 μM. Diosmetin significantly suppressed LPS‐induced mRNA and protein expression of pro‐inflammatory mediators, including COX‐2, IL‐1 β , and IL‐6. The MAPK and NF‐ κ B signaling pathways may represent the underlying mechanisms for its anti‐inflammatory effects. Quantitative analysis further revealed upregulated mRNA and protein levels of osteogenic markers—RUNX‐2, BMP‐2, and BSP, which may be associated with Wnt/ β ‐catenin signaling activation. Alkaline phosphatase (ALP) and alizarin red S (ARS) staining validate the osteogenic differentiation potential of diosmetin in hPDLCs. In the rat ligature‐induced periodontitis model, administration of diosmetin significantly reduced the RANKL/OPG ratio, potentially contributing to its inhibition of alveolar bone resorption.
Conclusion
This study demonstrated the dual roles of diosmetin's anti‐inflammatory and osteogenic differentiation effects in preventing periodontitis, along with a preliminary exploration of its underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Stomatological Hospital of Guizhou Medical University, Guizhou Medical University, Guiyang, China.
- The Stomatology of Guizhou Medical University, Guizhou Medical University, Guiyang, China.
ORCID-Profile: Yujun Lu, Jiaxu Liu, Changjun Huang, Yajing Wang
Förderung
- National Natural Science Foundation of China
- Guizhou Provincial Natural Science Foundation
- Science-Technology Foundation of Health Commission of Guizhou Province
- Fund of the Affiliated Stomatological Hospital of Guizhou Medical University
- Guizhou TCM and Ethnic Medicine Science & Technology Research Project
- Natural Science Foundation of Guizhou Province
Zitieren
APA
Lu, Y., Liu, J., Li, Z., Liang, Y., Li, W., Zhu, C., Huang, C., & Wang, Y. (2026). Flavonoid Diosmetin Prevents Periodontitis via Synergistic Anti‐Inflammatory and Osteogenic Effects: Dual In Vitro/In Vivo Validation. Oral Diseases, 32(9), 2898-2911. https://doi.org/10.1111/odi.70370
Vancouver
Lu Y, Liu J, Li Z, Liang Y, Li W, Zhu C, et al. Flavonoid Diosmetin Prevents Periodontitis via Synergistic Anti‐Inflammatory and Osteogenic Effects: Dual In Vitro/In Vivo Validation. Oral Diseases. 2026;32(9):2898-2911. doi:10.1111/odi.70370
BibTeX
@article{Lu2026,
author = {Lu, Yujun and Liu, Jiaxu and Li, Zhiyuan and Liang, Yuye and Li, Wenxiu and Zhu, Chengguang and Huang, Changjun and Wang, Yajing},
title = {Flavonoid Diosmetin Prevents Periodontitis via Synergistic Anti‐Inflammatory and Osteogenic Effects: Dual In Vitro/In Vivo Validation},
journal = {Oral Diseases},
year = {2026},
volume = {32},
number = {9},
pages = {2898--2911},
doi = {10.1111/odi.70370}
}
EUVIMED